Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Lisdexamfetamine in Post-bariatric Surgery Patients
NCT03070509Phase 4Unknown
- Sponsor
- North Dakota State University
- Start
- May 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lisdexamfetamine in attention deficit hyperactivity disorder (ADHD), binge eating disorder (BED), sponsored by North Dakota State University. Status: unknown.
02
Drugs
lisdexamfetamine
03
Conditions
attention deficit hyperactivity disorder (ADHD)binge eating disorder (BED)
Beyond the preview
Go deeper on NCT03070509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03070509.